PORT WASHINGTON, N.Y.– Aceto, a leading global virtual manufacturer of specialty materials for life sciences and advanced technology end markets, announced today the introduction of an expanded portfolio for biopharmaceutical and cell culture reagent manufacturers. This offering will be built on the established expertise of Pharma Waldhof, one of Aceto’s key facilities located in Düsseldorf, […]
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion from impact of COVID-19 pandemic Second quarter clinical laboratory revenue of $24.0 million increased 92% on significant volume and pricing growth due to improved product mix Consolidated quarterly gross margin of 50% improved 2000 basis points year-over-year Achieved adjusted EBITDA […]
SAN DIEGO —Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, has expanded its contract development and manufacturing organization (CDMO) capabilities at TriLink BioTechnologies (“TriLink”) with the launch of its plasmid DNA (pDNA) manufacturing services. TriLink’s new plasmid services empower customers with the ease of an end-to-end messenger RNA (mRNA) […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that its Bristol site in the United Kingdom received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for research use. This certification is widely […]
— Additional ‘Assay-Ready’ Controls for B.1.1.7 Now Available — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA reference controls, which include the new variant strains […]
We are launching Biozone 6, Fluicell’s new innovation for single-cell pharmacology that lets you perform drug testing and dose-response analysis directly on individual cells, using up to six different compounds or concentration levels. The flexible free-standing design, paired with an intuitive user interface, lets you readily integrate Biozone 6 into your research workflow. “Biozone 6 […]
Eurofins (Paris:ERF) adds virus variant monitoring capabilities to its commercially available SARS-CoV-2 test portfolio. This new solution is part of the Eurofins COVID-19 Sentinel™ and SAFER@WORK™ programs which provide an early warning of the presence of SARS-CoV-2 amongst large populations or at a given site (e.g. a city, factories, education institutions, government and public service […]
PALO ALTO, Calif.– HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) differentiated from adipose tissue-derived stromal cells (ASCs) using Namocell’s Single Cell Dispensers and Takara Bio’s SMART-seq® kits to characterize HepaTx’s novel cell therapies for liver disease. The results of […]
Shoreline Biome’ s microbiome products now available in Canada FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into a distribution partnership for the promotion, sale and support of all Shoreline Biome products and software in Canada. “Canada is experiencing significant […]
OrganaBio, LLC (“OrganaBio”) announces the launch of the HematoPAC™-HSC-CB CD34+ hematopoietic stem cell (HSC) product, designed to support development of HSC-based allogeneic cell therapies. These products provide a unique and timely solution to COVID-19 induced supply chain shortages that are hindering the cell therapy and immunotherapy industries. OrganaBio’s HematoPAC™-HSC-CB CD34+ hematopoietic stem cells (HSCs) are isolated […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
